These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33489469)

  • 21. COVID-19 and Cancer: Discovery of Difference in Clinical Immune Indexes.
    Zeng X; Jiang X; Yang L; Pan Y; Li Y
    J Immunol Res; 2021; 2021():8669098. PubMed ID: 34712741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimating the release of inflammatory factors and use of glucocorticoid therapy for COVID-19 patients with comorbidities.
    Han D; Peng C; Meng R; Yao J; Zhou Q; Xiao Y; Ma H
    Aging (Albany NY); 2020 Nov; 12(22):22413-22424. PubMed ID: 33232277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphocyte subsets as a predictor of severity and prognosis in COVID-19 patients.
    Zhang P; Du W; Yang T; Zhao L; Xiong R; Li Y; Geng Y; Lu W; Zhou J
    Int J Immunopathol Pharmacol; 2021; 35():20587384211048567. PubMed ID: 34619994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytokines and their relationship with the severity and prognosis of coronavirus disease 2019 (COVID-19): a retrospective cohort study.
    Liu QQ; Cheng A; Wang Y; Li H; Hu L; Zhao X; Wang T; He F
    BMJ Open; 2020 Nov; 10(11):e041471. PubMed ID: 33257492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of procalcitonin levels with the progression and prognosis of hospitalized patients with COVID-19.
    Liu ZM; Li JP; Wang SP; Chen DY; Zeng W; Chen SC; Huang YH; Huang JL; Long W; Li M; Gao RF; Guo L; Wu XH
    Int J Med Sci; 2020; 17(16):2468-2476. PubMed ID: 33029089
    [No Abstract]   [Full Text] [Related]  

  • 26. Immune reactivity during COVID-19: Implications for treatment.
    Napoli C; Benincasa G; Criscuolo C; Faenza M; Liberato C; Rusciano M
    Immunol Lett; 2021 Mar; 231():28-34. PubMed ID: 33421440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammatory markers in gynecologic oncology patients hospitalized with COVID-19 infection.
    Smith M; Lara OD; O'Cearbhaill R; Knisely A; McEachron J; Gabor L; Carr C; Blank S; Prasad-Hayes M; Frey M; Jee J; Fehniger J; Wang Y; Lee YC; Isani S; Wright JD; Pothuri B
    Gynecol Oncol; 2020 Dec; 159(3):618-622. PubMed ID: 33019984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality.
    Alosaimi B; Mubarak A; Hamed ME; Almutairi AZ; Alrashed AA; AlJuryyan A; Enani M; Alenzi FQ; Alturaiki W
    Front Immunol; 2021; 12():668725. PubMed ID: 34276659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytokine Profiles Before and After Immune Modulation in Hospitalized Patients with COVID-19.
    Azmy V; Kaman K; Tang D; Zhao H; Dela Cruz C; Topal JE; Malinis M; Price CC
    J Clin Immunol; 2021 May; 41(4):738-747. PubMed ID: 33459964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients.
    Contoli M; Papi A; Tomassetti L; Rizzo P; Vieceli Dalla Sega F; Fortini F; Torsani F; Morandi L; Ronzoni L; Zucchetti O; Pavasini R; Fogagnolo A; Volta CA; Bartlett NW; Johnston SL; Spadaro S; Campo G
    Front Immunol; 2021; 12():648004. PubMed ID: 33767713
    [No Abstract]   [Full Text] [Related]  

  • 31. Association Between Average Plasma Potassium Levels and 30-day Mortality During Hospitalization in Patients with COVID-19 in Wuhan, China.
    Liu S; Zhang L; Weng H; Yang F; Jin H; Fan F; Zheng X; Yang H; Li H; Zhang Y; Li J
    Int J Med Sci; 2021; 18(3):736-743. PubMed ID: 33437208
    [No Abstract]   [Full Text] [Related]  

  • 32. The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome.
    Blot M; Bour JB; Quenot JP; Bourredjem A; Nguyen M; Guy J; Monier S; Georges M; Large A; Dargent A; Guilhem A; Mouries-Martin S; Barben J; Bouhemad B; Charles PE; Chavanet P; Binquet C; Piroth L;
    J Transl Med; 2020 Dec; 18(1):457. PubMed ID: 33272291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral immunological features of COVID-19 patients in Taizhou, China: A retrospective study.
    Jin XH; Zhou HL; Chen LL; Wang GF; Han QY; Zhang JG; Zhang X; Chen QY; Ye YH; Lin A; Yan WH
    Clin Immunol; 2021 Jan; 222():108642. PubMed ID: 33253854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunophenotype of lymphocytes and real-world outcome of COVID-19 infection in children with hematology and oncology.
    Zhang N; Wang Z; Li H; Chen K; Wang HS; Shao JB; Jiang SY; Zhai XW; Jiang H
    BMC Cancer; 2024 Apr; 24(1):538. PubMed ID: 38678181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determinants of COVID-19 Mortality in Patients With Cancer From a Community Oncology Practice in Brazil.
    Ferrari BL; Ferreira CG; Menezes M; De Marchi P; Canedo J; Melo AC; Jácome AA; Reinert T; Paes RD; Sodré B; Barrios CH; Dienstmann R
    JCO Glob Oncol; 2021 Jan; 7():46-55. PubMed ID: 33434066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study.
    Yang K; Sheng Y; Huang C; Jin Y; Xiong N; Jiang K; Lu H; Liu J; Yang J; Dong Y; Pan D; Shu C; Li J; Wei J; Huang Y; Peng L; Wu M; Zhang R; Wu B; Li Y; Cai L; Li G; Zhang T; Wu G
    Lancet Oncol; 2020 Jul; 21(7):904-913. PubMed ID: 32479787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors associated with acute cardiac injury and their effects on mortality in patients with COVID-19.
    He X; Wang L; Wang H; Xie Y; Yu Y; Sun J; Yan J; Du Y; Shen Y; Zeng H
    Sci Rep; 2020 Nov; 10(1):20452. PubMed ID: 33235220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early Prediction of Disease Progression in Patients with Severe COVID-19 Using C-Reactive Protein to Albumin Ratio.
    Li Y; Li H; Song C; Lu R; Zhao Y; Lin F; Han D; Chen L; Pan P; Dai M
    Dis Markers; 2021; 2021():6304189. PubMed ID: 34900028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An immune-based biomarker signature is associated with mortality in COVID-19 patients.
    Abers MS; Delmonte OM; Ricotta EE; Fintzi J; Fink DL; de Jesus AAA; Zarember KA; Alehashemi S; Oikonomou V; Desai JV; Canna SW; Shakoory B; Dobbs K; Imberti L; Sottini A; Quiros-Roldan E; Castelli F; Rossi C; Brugnoni D; Biondi A; Bettini LR; D'Angio' M; Bonfanti P; Castagnoli R; Montagna D; Licari A; Marseglia GL; Gliniewicz EF; Shaw E; Kahle DE; Rastegar AT; Stack M; Myint-Hpu K; Levinson SL; DiNubile MJ; Chertow DW; Burbelo PD; Cohen JI; Calvo KR; Tsang JS; ; Su HC; Gallin JI; Kuhns DB; Goldbach-Mansky R; Lionakis MS; Notarangelo LD
    JCI Insight; 2021 Jan; 6(1):. PubMed ID: 33232303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Value of Immune-Inflammatory Index in PSI IV-V Patients with COVID-19.
    Han R; Su H; Guo G; Wang Q; Ma J; Li Z; Huang S; Ni Y; Hu R; Huang D; Zhou H
    Biomed Res Int; 2021; 2021():9987931. PubMed ID: 34423043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.